HCPCS code J1890: Injection, cephalothin sodium, up to 1 gram

Key Takeaways

HCPCS code J1890 describes injection, cephalothin sodium, up to 1 gram: a first-generation cephalosporin antibiotic previously billed under HCPCS Level II J-codes for Medicare and Medicaid drug administration claims.

J1890 is a deleted HCPCS code: submitting it on a Medicare or Medicaid claim today will result in an automatic denial. Always verify code status before billing.

No official CMS crosswalk replacement exists for J1890: practices billing for unclassified injectable drugs may use J3490 (unclassified drugs) or J3590 (unclassified biologics) with supporting documentation, subject to payer policy.

Pabau’s claims management software helps practices flag outdated HCPCS codes before submission, reducing denials from deleted or inactive codes.

HCPCS code J1890 is a Level II J-code that previously described the injection of cephalothin sodium, up to 1 gram. J-codes are a subset of HCPCS Level II maintained by the Centers for Medicare and Medicaid Services (CMS), and they cover injectable drugs administered in clinical settings. J1890 was used by outpatient facilities, physicians, and other eligible providers to bill Medicare and Medicaid when cephalothin sodium was administered by injection.

The code belongs to the J1600-J2060 range of HCPCS Level II, which groups antibiotic and antimicrobial drug injection codes. Like all J-codes, J1890 was specific to a defined drug and a maximum dosage unit: in this case, one gram of cephalothin sodium per billing encounter.

J1890 code details at a glance

The table below summarises the key reference data for HCPCS code J1890.

Is HCPCS code J1890 still active? Understanding its deleted status

HCPCS code J1890 is not active. CMS deleted it from the HCPCS Level II code set, meaning it cannot be used on current Medicare or Medicaid claims. Submitting J1890 on a claim today will trigger an automatic denial from the Medicare Administrative Contractor (MAC) processing the claim.

CMS updates HCPCS Level II codes on a quarterly basis, adding new codes, revising descriptors, and deleting codes for drugs that are no longer commercially available, no longer separately reimbursable, or reclassified under a different coding framework. Cephalothin sodium was withdrawn from the US market, which removed the clinical and billing basis for maintaining a specific J-code for the drug. For practices that need to track procedure codes for injectable drugs across specialties, keeping code references current is not optional.

Key implications of J1890’s deleted status:

• Any claim line submitted with J1890 as the procedure code will be denied by Medicare and most Medicaid programs.
• Practices auditing historical claims from the period when J1890 was active should note the code in documentation for reference but cannot reopen or recode those encounters using a deleted code retroactively without payer-specific guidance.
• Private payers may also reject J1890 if their systems have been updated to mirror HCPCS deletions, though this varies by plan.
• The deletion date should be verified directly from the AAPC HCPCS code lookup or the CMS HCPCS quarterly release files for your billing year.

Cephalothin sodium: The drug behind J1890

Cephalothin sodium is a first-generation cephalosporin antibiotic in the beta-lactam class. It was used to treat bacterial infections including skin and soft tissue infections, urinary tract infections, respiratory tract infections, and as a perioperative prophylactic antibiotic. When administered by injection in a clinical setting, it was billed under HCPCS code J1890 for Medicare and Medicaid reimbursement purposes.

The drug was sold under the brand name Keflin and was one of the earliest cephalosporins introduced to clinical practice. Its market withdrawal was driven by the availability of newer cephalosporins with broader spectra and improved tolerability profiles. For documentation purposes and when reviewing historical claims, drug billing documentation for cephalothin sodium administrations should record the drug name, dosage administered, route of administration, and the NDC (National Drug Code) number where applicable.

Clinical context for coders: J-codes are not mapped to diagnosis codes by CMS in the same way CPT codes are. However, the clinical indication for the antibiotic injection should be documented in the patient record and supported by an appropriate ICD-10-CM diagnosis code on the claim to establish medical necessity.

How J1890 was used for Medicare and Medicaid billing

When J1890 was an active HCPCS code, it was submitted on CMS-1500 claim forms (for physician offices and outpatient providers) and on UB-04 claim forms (for hospital outpatient departments). The code was placed in the procedure code field alongside the units administered, the administering provider’s NPI, and a supporting ICD-10-CM diagnosis code establishing medical necessity.

Billing J1890 required providers to document the drug name, dose administered, and route of administration in the clinical record. Sound medical billing compliance practices also called for noting the NDC number on the claim when billing Medicare Part B for separately payable drugs, as Medicare requires the NDC on drug claims for certain categories of injectables.

For practices billing injectable treatments across multiple drug codes, accurate unit documentation is especially important. Billing more units than administered is a common audit trigger, and J-codes for injectable drugs are among the code sets subject to CMS Correct Coding Initiative (CCI) edits.

Stop billing with outdated codes

Pabau’s claims management software helps your team flag deleted and inactive HCPCS codes before a claim goes out. Fewer denials, less rework, faster reimbursement.

Book a demo

J1890 crosswalk: Replacement and related HCPCS codes

CMS has not published an official crosswalk assigning a specific replacement code for J1890. Because cephalothin sodium is no longer commercially available in the United States, there is no currently marketed drug that maps directly to the old descriptor.

Practices that administered a cephalosporin antibiotic not covered by a specific J-code historically used unclassified drug codes. Those codes remain the appropriate mechanism when a specific injectable drug lacks its own HCPCS code.

The table below outlines the most relevant related codes for reference. These apply to drug injection billing broadly and should be verified against current payer policy before use. You can also review other procedure code schedules to understand how drug codes are structured across different systems.

When using J3490 for an unclassified drug injection, payers typically require a written description of the drug, dosage, route, and NDC number submitted alongside the claim. Some Medicare Administrative Contractors require prior authorization or a letter of medical necessity for unclassified drug claims. Always verify MAC-specific requirements before submission using the PGM Billing HCPCS lookup tool or by checking your MAC’s local coverage determinations.

What to do when a HCPCS code is deleted

A deleted HCPCS code on a live claim is a preventable denial. The process below applies whenever a J-code or other HCPCS Level II code your practice uses is removed from the active code set.

1. Confirm the deletion date. Check the CMS HCPCS quarterly update files or a verified lookup tool to confirm when the code was deleted and whether any grace period applies. CMS sometimes allows a short crossover window for claims with dates of service before the deletion date.
2. Identify affected claims. Run a report in your practice management system for any open or pending claims using the deleted code. Claims with dates of service before the deletion date and still within the timely filing window may be submitted with the old code for that period, subject to MAC policy.
3. Determine the appropriate replacement code. Use the official CMS crosswalk if one exists. If no crosswalk is published, consult your MAC’s local coverage determinations and consider whether an unclassified code applies. This is the step where denial management workflows matter most: having a defined protocol prevents ad hoc decisions that create inconsistent claim submissions.
4. Update your practice management system. Remove the deleted code from your active code library and add the replacement or unclassified alternative. For practices keeping code references current across multiple specialties, this is a quarterly maintenance task tied to the CMS update schedule.
5. Verify payer-specific rules. Medicare, Medicaid, and private payers may handle the transition period differently. Contact your MAC or review the payer’s billing guidelines before submitting claims using the replacement code for the first time. Aim for submitting clean claims from the first date of service under the new code.
6. Document the change. Note the effective date of the deletion and the replacement code decision in your coding protocol. This protects the practice in the event of a retrospective audit.

CMS publishes HCPCS Level II updates quarterly. Checking the CMS Physician Fee Schedule lookup and the HCPCS release notes at each quarterly cycle is the most reliable way to catch deletions before they cause claim denials. Practices that build this check into their billing calendar catch issues before claims go out rather than after.

How Pabau supports accurate HCPCS billing

Billing errors tied to deleted or inactive HCPCS codes are largely a systems problem. When a practice management platform doesn’t flag outdated codes at the point of claim creation, the error travels through to submission. Pabau’s claims management software gives billing teams visibility over the claim lifecycle, from code entry through submission and payment posting.

For practices managing drug administration billing across multiple providers or locations, the operational challenge is consistency: ensuring that every claim uses a current, payer-accepted code rather than a deleted one from a prior year. Pabau’s billing workflows support that consistency by centralising claim creation and giving practice managers a single point of review before claims are submitted.

Effective revenue cycle management depends on catching code-level errors early. A denied claim for a deleted HCPCS code requires the billing team to identify the correct replacement, update the claim, and resubmit within the timely filing window. Each of those steps adds time and cost. Pabau’s reporting tools make it possible to identify patterns in denial reasons, so practices can address root causes rather than working denials one claim at a time.

Conclusion

HCPCS code J1890 is a deleted code. It once covered the injection of cephalothin sodium, up to 1 gram, for Medicare and Medicaid billing. Today, submitting it on a claim results in an automatic denial. Coders encountering J1890 in historical records should treat it as a reference point, not a billable code.

For practices managing active drug injection billing, the risk isn’t limited to J1890. Any practice that hasn’t reviewed its HCPCS code library against the current quarterly update is exposed to the same denial pattern. Pabau’s claims management software supports proactive billing workflows that reduce the cost of deleted-code denials. Book a demo to see how it works in practice.

Continue your research

Need to understand how medical billing works end to end? What is medical billing covers the full claim lifecycle from documentation through reimbursement.

Want a framework for managing claim denials systematically? Denial management in healthcare outlines the key steps practices use to reduce and resolve denied claims.

Exploring how RCM strategy connects to billing accuracy? Revenue cycle management fundamentals explains how billing, coding, and payment posting work together.

Frequently Asked Questions